Investors

Investors

Medovent is funded by a group of renowned private and institutional investors, including:

 

High-Tech Gründerfonds

Logo High-Tech Gründerfonds

High-Tech Gründerfonds Management GmbH invests venture capital in innovative, high-opportunity technological companies. The German government, the KfW Kreditanstalt für Wiederaufbau, BASF, Deutsche Telekom and Siemens provided jointly investment capital as part of the "Partners for Innovation" fund.

http://www.high-tech-gruenderfonds.de/

 

WFT and FIB funds Rhineland-Palatinate

Logo FIB

WFT and FIB are subsidiaries of Investitions- und Strukturbank Rheinland-Pfalz (ISB) GmbH, which is the central economic development agency of the province of Rhineland-Palatinate and KfW Kreditanstalt für Wiederaufbau. WFT and FIB support small and medium-sized businesses by providing investments and loans.

http://www.isb.rlp.de/

 

 ERDF

   |--efre_logo.png

Our company was financed with equity capital of the Rhineland-Palatinate Innovation Fund. This fund provides young, technology-oriented companies in Rhineland-Palatinate venture capital available. Thus, the capital of the Company's financial condition improved and created a successful startup technology companies. The capital of Rhineland-Palatinate Innovation Fund was endowed with funds from the European Regional Development Fund (ERDF) and national co-financing.

..................................................................................................................................

For more information please see our News.

Contact

For more information:

Medovent GmbH
Friedrich-Koenig-Strasse 3
55129 Mainz

Tel.: +49 (0) 6131 61769 0
Fax: +49 (0) 6131 61769 29

Email: mail@medovent.com

Our contact form

News

Medovent started the commercialization of pure chitosan microfibers for tissue engineering research as well as reinforcement for medical implants.

Medoderm starts clinical study - first patients treated with chitosan woundspray